Xueyee Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xueyee Lim has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ling Li
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2 shared publications Fanruo Gu
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China
1 shared publicationJianlong Yuan
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People’s Republic of China
1 shared publicationJing Li
1 shared publication- Pei-Rong Song1 shared publication
Tong Zhang
1 shared publication
Latest Publications
- Open Access
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
A chemometric framework for tracking quality value transmission in herbal volatile oil processing: From raw material to cyclodextrin inclusion complex
Objective: To develop a quality value transmission framework for volatile oil preparations based on the β-cyclodextrin inclusion (IC) of Atractylodes macrocephala Koidz. volatile oil (AO). Methods: The IC were prepared via a self-emulsifying strategy guided by molecular simulation. TLC, HPLC fingerprints and contents of 5 components were performed on 15 batches of herb, AO, and IC. A quality value transmission framework was established mainly using Crystal Ball simulation and bootstrap resampling, which virtually amplify the 15-batch preparation data using only Microsoft Excel calculations. Results: Atractylone (ATR) dominated the IC formation through van der Waal forces and self-emulsifying strategy. The chemical profiles from conventional analysis showed that ATR, β-caryophellene jointly indicate sample freshness and high quality of samples, whereas atractylenolides should be limited across herb-AO-IC process. Spearman correlation confirmed the rationality of conventional analysis and clarified the setting of Q-markers based on chemical distribution between and within samples. Crystal ball and Boostrap resampling further demonstrated that the key component ATR should exceed 560, 240 mg/g in AO, IC, respectively, to ensure the stability of process. Conclusion: The proposed multivariate quality value transmission method support Quality-by-Design concept and rational quality control for drug development of complex.
- 10 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA chemometric framework for tracking quality value transmission in herbal volatile oil processing: From raw material to cyclodextrin inclusion complex
Objective: To develop a quality value transmission framework for volatile oil preparations based on the β-cyclodextrin inclusion (IC) of Atractylodes macrocephala Koidz. volatile oil (AO). Methods: The IC were prepared via a self-emulsifying strategy guided by molecular simulation. TLC, HPLC fingerprints and contents of 5 components were performed on 15 batches of herb, AO, and IC. A quality value transmission framework was established mainly using Crystal Ball simulation and bootstrap resampling, which virtually amplify the 15-batch preparation data using only Microsoft Excel calculations. Results: Atractylone (ATR) dominated the IC formation through van der Waal forces and self-emulsifying strategy. The chemical profiles from conventional analysis showed that ATR, β-caryophellene jointly indicate sample freshness and high quality of samples, whereas atractylenolides should be limited across herb-AO-IC process. Spearman correlation confirmed the rationality of conventional analysis and clarified the setting of Q-markers based on chemical distribution between and within samples. Crystal ball and Boostrap resampling further demonstrated that the key component ATR should exceed 560, 240 mg/g in AO, IC, respectively, to ensure the stability of process. Conclusion: The proposed multivariate quality value transmission method support Quality-by-Design concept and rational quality control for drug development of complex.
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-23
Chinese Herbal Medicine in Ulcerative Colitis-Associated Carcinogenesis Treatment: Mechanisms, Progress, and Future Directions
Colitis-associated colorectal cancer (CAC) is a highly prevalent malignancy of the digestive tract. The close association between ulcerative colitis (UC) and CAC makes inhibiting this carcinogenic transformation a critical preventive goal. Based on traditional Chinese medicine (TCM) theories of “dampness-heat stasis” and “latent pathogen-induced deficiency”, this review systematically explores the pathological process of ulcerative colitis associated carcinogenesis (UCAC) and its interpretation in TCM. We conducted a comprehensive literature search in CNKI and PubMed databases (2020– 2025), systematically analyzing about 79 relevant studies to summarize the clinical applications of TCM in preventing and treating UCAC progression, including oral and topical herbal therapies, as well as non-pharmacological interventions such as acupuncture. Furthermore, we elucidate the underlying mechanisms of TCM interventions in UCAC, with a focus on gut microbiota modulation and key inflammatory signaling pathways (eg, NF-κB, IL-6/JAK2/STAT3), offering new translational perspectives. The novelty of this review is twofold: firstly, it provides the first systematic synthesis of research progress on therapeutic methods, encompassing oral and topical herbal formulations as well as acupuncture, and molecular mechanisms of TCM for UCAC. Secondly, it advances the field by analyzing TCM theories through the lens of modern medicine, comparing TCM’s holistic approach with Western medicine’s targeted paradigm, and proposing an integrated “gut microbiota-metabolite-target” research framework. This framework aims to furnish a theoretical foundation for both the modernization of TCM and the development of combined therapeutic strategies that leverage the strengths of both medical systems.
- 1 February 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-23
Open AccessChinese Herbal Medicine in Ulcerative Colitis-Associated Carcinogenesis Treatment: Mechanisms, Progress, and Future Directions
Colitis-associated colorectal cancer (CAC) is a highly prevalent malignancy of the digestive tract. The close association between ulcerative colitis (UC) and CAC makes inhibiting this carcinogenic transformation a critical preventive goal. Based on traditional Chinese medicine (TCM) theories of “dampness-heat stasis” and “latent pathogen-induced deficiency”, this review systematically explores the pathological process of ulcerative colitis associated carcinogenesis (UCAC) and its interpretation in TCM. We conducted a comprehensive literature search in CNKI and PubMed databases (2020– 2025), systematically analyzing about 79 relevant studies to summarize the clinical applications of TCM in preventing and treating UCAC progression, including oral and topical herbal therapies, as well as non-pharmacological interventions such as acupuncture. Furthermore, we elucidate the underlying mechanisms of TCM interventions in UCAC, with a focus on gut microbiota modulation and key inflammatory signaling pathways (eg, NF-κB, IL-6/JAK2/STAT3), offering new translational perspectives. The novelty of this review is twofold: firstly, it provides the first systematic synthesis of research progress on therapeutic methods, encompassing oral and topical herbal formulations as well as acupuncture, and molecular mechanisms of TCM for UCAC. Secondly, it advances the field by analyzing TCM theories through the lens of modern medicine, comparing TCM’s holistic approach with Western medicine’s targeted paradigm, and proposing an integrated “gut microbiota-metabolite-target” research framework. This framework aims to furnish a theoretical foundation for both the modernization of TCM and the development of combined therapeutic strategies that leverage the strengths of both medical systems.